Cargando…
Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
Treatment of many cancers, particularly those that remain difficult to treat or are refractive after standard-of-care therapies, has been challenging with cell-based therapies. Although relatively safe as allogeneic therapies and innately effective against cancers without the need for antigen sensit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676278/ https://www.ncbi.nlm.nih.gov/pubmed/36420307 http://dx.doi.org/10.1016/j.omto.2022.10.011 |